Category Archive: Cancer stem cells

Jul 02

Inaugural Woodward family endowment for excellence in NDNANO undergraduate research awarded to Margo Waters

Congratulations to Margo Waters of the Nallathamby lab for having being selected for the Inaugural Woodward family endowment for excellence in NDnano undergraduate research! Margo has been an exceptional contributor to advancing research on novel cancer therapeutics in our lab. You can check out more about what motivates her at

May 01

CD133+ Cancer Stem Cells Role in Metastasis

Excited for the 2nd publication this year through collaborative efforts with Harper Cancer Research Institute’s Karen Dahl (Title: CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche). I did the 3D confocal imaging that showed CD133+ ovarian cancer cells clearly penetrate the basal epithelial cells, pointing to metastatic potential of stem cell like cancer cells. Looking …

Continue reading »

Apr 01

MRS 2018 Spring Symposium,

I will be at MRS 2018 from April 1 to April 5 presenting my work on novel cancer therapeutics Title: Biocompatible, Radiotherapeutic Hafnium Oxide Nanoparticle Imaging Probes Prepared Using a Novel Templated Synthesis Abstract Control ID: # 2884959 Paper # NM05.01.05 Presentation Date: April 2, 2018 Presentation Time: 9:30 AM to 9:45 AM Location: PCC …

Continue reading »

Nov 05

Dual Mode CT/Fluorescence Detectable Immunotargeted Nanoparticle Probes to Identify Self-Renewing Cancer Cells In Vivo

Statement of Purpose: The high mortality and poor prognosis for women diagnosed with ovarian cancer is mainly due to late diagnosis. Improved detection of primary tumors and recurring tumors after chemotherapy is, therefore, crucial to reduce ovarian cancer mortality and improve progression-free survival. However, current clinical screening and diagnostic imaging methods are limited by low …

Continue reading »